Reduction of thrombogenicity with lipids of blackcurrant seed

Details Reduction of thrombogenicity with lipids of blackcurrant seed Reduction of thrombogenicity with lipids of blackcurrant seed

1992-05-28

1993-08-10

Rollins, John W.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Radical -xh acid, or anhydride, acid halide or salt thereof...

514822, 514824, A61K 3120

Patent

active

052349527

ABSTRACT:
Lipids obtained from blackcurrant seed are used for reducing thrombogenicity of blood vessels in humans.

REFERENCES:
patent: 4526793 (1985-07-01), Ingenbleek et al.
patent: 4776984 (1988-10-01), Traitler et al.
patent: 4888326 (1989-12-01), Horrobin
patent: 5130449 (1992-07-01), Legarde et al.
Horrobin "A New Concept of Lifestyle-Related Cardiovascular Disease: The Importance of Interactions Between Cholesterol, Essential Fatty Acids, Prostaglandin E1 and Thromboxane A2", Medical Hypotheses 6:785-800, 1980.
Horrobin, "Evening Primrose Oil Miracle Worker of the Eighties", The Health Quarterly, vol. 6, No. 5, Sep./Oct. 1981 pp. 18, 19, 70 and 71.
Traitler, et al., Fette Seifen, Anstrichmittel, vol. 88, No. 10, pp. 378-382, 1986, and translation thereof, entitled "Fractionation of Poly-Unsaturated Fatty Acids from Various Natural Raw Materials".
Traitler, et al., "Fractionation of Blackcurrant Seed Oil", JAOCS, vol. 65, No. 5 (May 1988).

Affiliated with

Also associated with

Rating

Reduction of thrombogenicity with lipids of blackcurrant seed does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Reduction of thrombogenicity with lipids of blackcurrant seed, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Reduction of thrombogenicity with lipids of blackcurrant seed will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1725545